Barclays analyst Peter Lawson maintained a Buy rating on MacroGenics (MGNX – Research Report) today and set a price target of $8.00. The ...
That control is starting to fray as Mr. Johnson, a longevity guru known for performing experiments on his body, faces a ...
These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They include: ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback